We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$335M
Cap. Flow %
-50.06%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.26M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 7.59%
2 Technology 1.45%
3 Financials 0.54%
4 Consumer Discretionary 0.53%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TANH icon
51
Tantech Holdings
TANH
$6.25M
$734K 0.11%
1,605
+960
+149% +$2.26M
SBEV icon
52
PUT
Splash Beverage Group
SBEV
$2.15M
$733K 0.11%
+16
New +$8.16K
HCDIZ
53
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$730K 0.11%
1,973,494
+62,720
+3% +$27.4K
NMTR
54
CALL
DELISTED
9 Meters Biopharma
NMTR
$687K 0.1%
79
-19
-19% -$259
IMPP icon
55
PUT
Imperial Petroleum
IMPP
$213M
$604K 0.09%
+278
New +$7.86K
BIOR
56
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$599K 0.09%
21
-10
-32% -$3.79K
BIOR
57
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$579K 0.09%
1,997
-2,338
-54% -$887K
XWEL icon
58
PUT
XWELL
XWEL
$9.04M
$557K 0.08%
246
-354
-59% -$9.48K
SPI
59
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$550K 0.08%
+191,624
New +$613K
OLB icon
60
OLB
OLB
$4.51M
$498K 0.07%
28,460
-13,612
-32% -$260K
LFWD icon
61
PUT
ReWalk Robotics
LFWD
$20M
$493K 0.07%
51
+4
+9% +$377
ATOS icon
62
Atossa Therapeutics
ATOS
$23.7M
$453K 0.07%
+24,138
New +$490K
NRXP icon
63
PUT
NRX Pharmaceuticals
NRXP
$149M
$444K 0.07%
181
-60
-25% -$1.95K
GFAIW icon
64
Guardforce AI Warrant
GFAIW
$443K 0.07%
1,163,566
+103,357
+10% +$28.3K
AMPGW
65
DELISTED
Amplitech Group Warrants
AMPGW
$438K 0.07%
455,920
+14,057
+3% +$13.5K
KUST
66
Kustom Entertainment Inc
KUST
$646K
$434K 0.06%
1
– –
CFRX
67
CALL
DELISTED
ContraFect Corporation
CFRX
$414K 0.06%
+14
New +$3.4K
AMPG icon
68
AmpliTech
AMPG
$127M
$411K 0.06%
122,400
-7,200
-6% -$23.5K
VTGN icon
69
PUT
VistaGen Therapeutics
VTGN
$9.7M
$389K 0.06%
105
-6
-5% -$262
LEXXW
70
DELISTED
Lexaria Bioscience Warrant
LEXXW
$383K 0.06%
425,883
+17,069
+4% +$19.2K
VEEE icon
71
Twin Vee PowerCats
VEEE
$7.68M
$378K 0.06%
245
– –
SMFL
72
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$369K 0.06%
+105
New +$367K
KUST
73
PUT
Kustom Entertainment Inc
KUST
$646K
– –
0
– –
SBEV icon
74
Splash Beverage Group
SBEV
$2.15M
$348K 0.05%
+767
New +$391K
CFRX
75
DELISTED
ContraFect Corporation
CFRX
$343K 0.05%
1,175
-1,221
-51% -$297K
1 2
3
4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $335M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.26M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.